Back to Trades
Other3
Kailera Therapeutics, Inc.
KLRA
Total Value
$NaN
Company Information
- Company Name
- Kailera Therapeutics, Inc.
- Ticker Symbol
- KLRA
- CIK
- 0002096997
Insider Information
- Name
- Kaplan Andrew T.
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Apr 16, 2026
- Transaction Date
- Apr 16, 2026
- Accession Number
- 0001193125-26-159757
- Form Type
- 3
Footnotes
- (F1)Each share of the Issuer's Series B Preferred Stock is convertible, at the option of the holder, into shares of the Issuer's Common Stock on a 1:1 basis and will automatically convert upon the closing of the Issuer's initial public offering. These securities have no expiration date.
- (F2)Represents shares of the Issuer's Series B Preferred Stock held directly by BCPE Perseus Investor, LP ("BCPE Perseus").
- (F3)Mr. Kaplan is a Partner of Bain Capital Investors, LLC ("BCI"). BCI is the ultimate general partner of BCPE Perseus. As a result, Mr. Kaplan may be deemed to share voting and dispositive power with respect to the securities held by BCPE Perseus. Mr. Kaplan disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.